本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Sarepta Therapeutics

62.40
+1.552.55%
盘后62.400.00000.00%16:05 EDT
成交量:177.04万
成交额:1.09亿
市值:60.55亿
市盈率:26.69
高:62.51
开:59.98
低:59.62
收:60.85
数据加载中...
2024/03/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/28

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/28

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/09

重要事件披露

Form 8-K - Current report
2023/11/01

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/08/02

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/02

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/06/23

重要事件披露

Form 8-K - Current report
2023/06/23

重要事件披露

Form 8-K - Current report
2023/06/09

重要事件披露

Form 8-K - Current report